| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/04/2013 | CA2858336A1 Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents |
| 07/04/2013 | CA2856347A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/04/2013 | CA2856309A1 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors |
| 07/04/2013 | CA2855182A1 Pharmaceutical compositions for the treatment of tumours that express egfr and ganglioside n-glycolyl gm3 (neugcgm3) |
| 07/03/2013 | EP2610267A1 Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases |
| 07/03/2013 | EP2610261A1 Ibandronate polymorph B |
| 07/03/2013 | EP2610260A1 Crystal of tricyclic pyrazolopyrimidine derivative |
| 07/03/2013 | EP2610259A1 Free crystal of tricyclic pyrazolopyrimidine derivative |
| 07/03/2013 | EP2610257A1 Diimidated derivative of berbamine, and preparation method therefor and use thereof |
| 07/03/2013 | EP2610256A1 Pyrimidine derivatives as protein kinase inhibitors |
| 07/03/2013 | EP2609936A1 Method for making rhenium-186/188 labeled human serum albumin microspheres and kit for making the same and method for using the kit |
| 07/03/2013 | EP2609934A1 Receptor And Antigen Targeted Prodrug |
| 07/03/2013 | EP2609932A2 Variant target binding agents and uses thereof |
| 07/03/2013 | EP2609925A2 Dermatan sulfate for use in the treatment of pathologies wherein metalloproteinases are involved |
| 07/03/2013 | EP2609920A1 Method of treating cancer by a combined therapy of YM-155 with other anticancer agents |
| 07/03/2013 | EP2609919A2 c-Met modulators and methods of use |
| 07/03/2013 | EP2609118A2 Anti-ox40 antibodies and methods of using the same |
| 07/03/2013 | EP2609108A1 Certain chemical entities, compositions, and methods |
| 07/03/2013 | EP2609092A1 Oxadiazole inhibitors of leukotriene production |
| 07/03/2013 | EP2609091A1 Pharmaceutically active compounds as axl inhibitors |
| 07/03/2013 | EP2609087A2 Pure intermediate |
| 07/03/2013 | EP2609082A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors |
| 07/03/2013 | EP2609064A2 Pharmaceutical compositions comprising poh derivatives |
| 07/03/2013 | EP2608811A1 Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates |
| 07/03/2013 | EP2608808A2 Treatment for neoplastic diseases |
| 07/03/2013 | EP2608802A2 Immunotherapeutic method for treating prostate cancer |
| 07/03/2013 | EP2608799A2 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
| 07/03/2013 | EP2608792A1 Methods of administering an egfr inhibitor |
| 07/03/2013 | EP2608790A1 Pharmaceutical combination of a vegfr inhibitor and a mek inhibitor useful for treating cancer |
| 07/03/2013 | EP2608671A1 Compounds for treatment of cancer |
| 07/03/2013 | EP2608668A1 Fused tricyclic inhibitors of mammalian target of rapamycin |
| 07/03/2013 | EP2207809B1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 07/03/2013 | CN203029653U Chinese patent medicine pill resistant to gastrointestinal tumors |
| 07/03/2013 | CN203029651U Anticancer traditional Chinese medicine tablets |
| 07/03/2013 | CN103189511A Method for producing novel hiPSC by means of siRNA introduction |
| 07/03/2013 | CN103189510A TTLL4 peptides and vaccines containing the same |
| 07/03/2013 | CN103189392A ErbB3 binding antibody |
| 07/03/2013 | CN103189379A Bicyclic pyrimidines |
| 07/03/2013 | CN103189378A Pyrazolopyridinone derivatives as LPA receptor antagonists |
| 07/03/2013 | CN103189373A Substituted triazolopyridines |
| 07/03/2013 | CN103189369A Pyridinones/pyrazinones, method of making, and method of use thereof |
| 07/03/2013 | CN103189361A Estrogen receptor modulators and use thereof |
| 07/03/2013 | CN103189067A Inhibition of WDR5 interaction with its binding partners and therapeutic methods |
| 07/03/2013 | CN103189063A Therapeutic compositions and methods |
| 07/03/2013 | CN103189061A 4- (methylaminophenoxy) pyrdin- 3 - yl - benzamide derivatives for treating cancer |
| 07/03/2013 | CN103189060A Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 07/03/2013 | CN103189059A Method of treating refractory cancer |
| 07/03/2013 | CN103184234A Tumor antigens BFA5 for prevention and/or treatment of cancer |
| 07/03/2013 | CN103184223A Si RNA (small interfering RNA) used for supressing tumors and application thereof |
| 07/03/2013 | CN103184209A Homosapiensarginase and pegylation homosapiensarginase as well as applications thereof |
| 07/03/2013 | CN103184208A Homosapiensarginase and fixed-point pegylation homosapiensarginase as well as applications thereof |
| 07/03/2013 | CN103184170A Novel Lactobacillus LY-73 and its application |
| 07/03/2013 | CN103184130A Health-maintaining wine and preparation method |
| 07/03/2013 | CN103183739A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 07/03/2013 | CN103183738A Compositions and methods of use for antibodies of c-MET |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183724A Preparation method of docetaxel conjugate |
| 07/03/2013 | CN103183722A Glyoxalase I inhibitor, preparation method and medical application thereof |
| 07/03/2013 | CN103183717A Antineoplastic pentacyclic triterpenoid and extraction method thereof |
| 07/03/2013 | CN103183697A Near-infrared boron dipyrromethene (BODIPY) compound based on duplex heterocyclic pyrrole group, and preparation method and application of BODIPY compound |
| 07/03/2013 | CN103183682A C-10 site carbamido substituted artemisinin derivative, preparation method and application |
| 07/03/2013 | CN103183681A New crystal form of ixabepilone, and preparation method thereof |
| 07/03/2013 | CN103183674A Fused heterocycle derivative and application thereof |
| 07/03/2013 | CN103183668A Derivative of natural product Mansonone E and preparation and application thereof |
| 07/03/2013 | CN103183666A Cyclopiazonic acid compound, and preparation and application thereof |
| 07/03/2013 | CN103183665A Substance having tyrosine kinase inhibition activity, preparation method and application |
| 07/03/2013 | CN103183655A Nor-sesquiterpenoid compound as well as preparation method and application thereof |
| 07/03/2013 | CN103183640A Diaryl pyrazole compound, and preparation method and purpose thereof |
| 07/03/2013 | CN103183627A 1,2-diaryl-5-substituted-1H-pyrrole compounds, and preparation method and application thereof |
| 07/03/2013 | CN103183625A Anti-HIV compound and preparation method and application thereof |
| 07/03/2013 | CN103183598A 1,2-diaryl-2-propenyl-1-ketone compounds and use thereof |
| 07/03/2013 | CN103183597A Diaryl neptanone compound having antineoplastic activity, preparing method and application |
| 07/03/2013 | CN103182090A Dna疫苗 Dna Vaccine |
| 07/03/2013 | CN103182089A Cell-mediated gene therapy for cancer using mesenchymal stem cells expressing a suicide gene |
| 07/03/2013 | CN103182083A Multifunctional anticancer nanometer medicine carrying controlled-release vesicle and preparation process thereof |
| 07/03/2013 | CN103182073A Pharmaceutical injection of recombinant human interferon alpha-CTP fusion protein |
| 07/03/2013 | CN103182068A Application of cyclic lipopeptide Fengycin in preparation of antineoplastic drug |
| 07/03/2013 | CN103182063A Chinese patented drug pill for treating cancer |
| 07/03/2013 | CN103182056A Preparation method of zedoary oil |
| 07/03/2013 | CN103182055A Enteric-coated capsules comprising blue turmeric rhizome extract |
| 07/03/2013 | CN103182050A Formula of traditional Chinese medicine used for treating lymphoma, and production method thereof |
| 07/03/2013 | CN103182016A 中药组合物及其制备方法 Chinese medicine composition and its preparation method |
| 07/03/2013 | CN103182006A 中药组合物及其制备方法 Chinese medicine composition and its preparation method |
| 07/03/2013 | CN103181998A Freeze-dried solanum pseudo-capsicumvar diflorum (Vell.) Bitter for treating cancers |
| 07/03/2013 | CN103181997A Method for processing bittersweet herb |
| 07/03/2013 | CN103181996A Solanum pseudo-capsicumvar diflorum (Vell.) Bitter for treating cancers |
| 07/03/2013 | CN103181995A Processing method of twoflower jerusalemcherry |
| 07/03/2013 | CN103181994A Solanum pseudo-capsicumvar diflorum (Vell.) Bitter fruit for treating cancers |
| 07/03/2013 | CN103181993A Solanum lytatum thunb fruit for treating cancers |
| 07/03/2013 | CN103181992A Nightshade processing method |
| 07/03/2013 | CN103181991A Freeze-dried solanum lytatum thunb fruit for treating cancers |
| 07/03/2013 | CN103181990A Fresh solanum pseudo-capsicumvar diflorum (Vell.) Bitter for treating cancers |
| 07/03/2013 | CN103181988A Freeze-dried black nightshade for treating cancers |
| 07/03/2013 | CN103181987A Solanum septemlobum bunge fruit for treating cancers |
| 07/03/2013 | CN103181985A Black nightshade fruit for treating tumors |
| 07/03/2013 | CN103181982A Medicine for treating cancer |
| 07/03/2013 | CN103181980A Processing method of dulcamara |
| 07/03/2013 | CN103181979A Freeze-dried nigrum fruit with function of treating tumor |
| 07/03/2013 | CN103181978A Freeze-dried solanum septemlobum bunge for treating cancers |
| 07/03/2013 | CN103181971A Heartleaf houttuynia herb oil enteric-coated capsules |